➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Express Scripts
Johnson and Johnson
McKesson
McKinsey

Last Updated: September 21, 2021

DrugPatentWatch Database Preview

Claims for Patent: 9,296,694


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,296,694
Title:Azacyclic compounds
Abstract: Compounds and methods are provided for the treatment of disease conditions in which modification of serotonergic receptor activity has a beneficial effect. In the method, an effective amount of a compound is adminstered to a patient in need of such treatment.
Inventor(s): Andersson; Carl-Magnus A. (Glostrup, DK), Croston; Glenn (San Diego, CA), Hansen; Eva Louise (Glostrup, DK), Uldam; Allan Kjaersgaard (Glostrup, DK)
Assignee: ACADIA PHARMACEUTICALS INC. (San Diego, CA)
Application Number:14/628,156
Patent Claims: 1. A compound of formula (I) ##STR00010## or a pharmaceutically acceptable salt thereof, wherein Z is ##STR00011## in which R is a hydrogen, a lower alkyl group, a cyclic organyl group, or a substituted or unsubstituted aralkyl or heteroaralkyl group; and n is 1; X.sub.1 is NH or N(lower alkyl) group; X.sub.2 is methylene; Y.sub.1 is methylene; Y.sub.2 is a bond, methylene, ethylene, or vinylene; Ar.sub.1 and Ar.sub.e are phenyl groups p-substituted with a substituent selected from the group consisting of lower alkyl, lower alkoxy and halogen; and W is oxygen.

2. The compound or pharmaceutically acceptable salt of claim 1, wherein R is a lower alkyl group.

3. The compound or pharmaceutically acceptable salt of claim 2, wherein R is selected from the group consisting of methyl, ethyl, propyl, butyl, methylbutyl, cyclopropyl, cyclohexyl, iso-propyl and tert-butyl.

4. The compound or pharmaceutically acceptable salt of claim 2, wherein aR.sub.1 and Ar.sub.2 are p-substituted with different substituents.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Moodys
Dow
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.